Level Four Advisory Services, LLC Unity Biotechnology, Inc. Transaction History

Level Four Advisory Services, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Oct 12, 2021	SELL	$2.91 - $4.5 $34,076 - $52,695	-11,710 Closed	0 $0
Q1 2021 May 10, 2021	SELL	$5.51 - $9.42 $18,623 - $31,839	-3,380 Reduced 22.4%	11,710 $70,000
Q2 2020 Aug 17, 2020	BUY	$5.28 - $9.67 $79,675 - $145,920	15,090 New	15,090 $132,000
Q2 2020 Jul 27, 2020	SELL	$5.28 - $9.67 $79,675 - $145,920	-15,090 Closed	0 $0
Q3 2019 Nov 12, 2019	BUY	$5.62 - $9.63 $84,805 - $145,316	15,090 New	15,090 $92,000

4.41M

Ticker UBX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 14,036,200
Market Cap $16.1M
Description
Unity Biotechnology, Inc., a biotechnology company, engages in the research and development of therapeutics to slow, halt, or reverse diseases of aging. The company's lead drug candidate includes UBX1325, which is Phase II clinical trial for the treatment of age-related diseases of the eye, including diabetic macular edema, age-related macular d...

Get notified when there are updates to the investment portfolio of Level Four Advisory Services, LLC, based on Form 13F filings with the SEC.

Stay updated on Level Four Advisory Services, LLC with notifications on news.